Sodium polydihydroxyphenylene thiosulfonate
Chemical compound
From Wikipedia, the free encyclopedia
Sodium polydihydroxyphenylene thiosulfonate (гипоксен, Hypoxen) is under laboratory studies in Russia as a potential regulator of cell metabolism.[1]
| |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| UNII | |
| Chemical and physical data | |
| Formula | C12+6nH9+4nNaO7+2nS2 |
It is registered in Russia as an antihypoxic agent, but has not been subjected to any clinical trials meeting internationally accepted standards, and has no regulatory approval as a prescription drug outside Russia and some former Soviet states.
It has been identified in tests on athletes in competition, such as Kamila Valieva, a Russian figure-skater competing at the 2022 Winter Olympics, but is not itself banned in international competitions, as of 2022.[2][3]
Potential abuse in sports
Although called an "oxygen booster" in public media to imply its potential to "increase endurance and reduce fatigue",[4] there is no scientific evidence it has this property, and it is not used in conventional cardiology as a therapy for treating heart disease.[5]
Hypoxen is sold online without a prescription, mainly from Russian websites, and does not appear to be sold in health stores in the United States.[5] Hypoxen is not listed on the prohibited substance list of the World Anti-Doping Agency.[5] In 2017, the United States Anti-Doping Agency applied to have hypoxen banned from athletic competitions, but the ban was not implemented.[4]
